|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1996-12-17
|
|
pubmed:abstractText |
To determine whether the proportion of total serum prostate-specific antigen (tPSA) which is unbound or free (free PSA) offers a better discriminant for the detection of patients with prostate cancer (CaP) and those with benign prostatic hyperplasia (BPH) than does serum tPSA alone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0007-1331
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
409-13
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8881952-Aged,
pubmed-meshheading:8881952-Aged, 80 and over,
pubmed-meshheading:8881952-Humans,
pubmed-meshheading:8881952-Male,
pubmed-meshheading:8881952-Middle Aged,
pubmed-meshheading:8881952-Neoplasm Metastasis,
pubmed-meshheading:8881952-Prostate-Specific Antigen,
pubmed-meshheading:8881952-Prostatic Hyperplasia,
pubmed-meshheading:8881952-Prostatic Neoplasms,
pubmed-meshheading:8881952-Retrospective Studies,
pubmed-meshheading:8881952-Sensitivity and Specificity
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia.
|
|
pubmed:affiliation |
Department of Urology, RWTH Aachen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
